Prefilled Syringes Market (By Type: Disposable, Reusable; By Material: Glass, Plastic; By Application: Anaphylaxis, Diabetes; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Prefilled Syringes Market Size and Growth 2024 to 2033

The global prefilled syringes market size was valued at USD 7.28 billion in 2023 and it is predicted to surpass around USD 24.91 billion by 2033 with a CAGR of 13.09% from 2024 to 2033. Prefilled syringes have become a crucial component in the pharmaceutical and healthcare industries, offering significant advantages in terms of ease of use, dosage accuracy, and patient compliance. This market has witnessed substantial growth due to the increasing demand for self-administration of medications, the rise in chronic diseases, and advancements in pharmaceutical technologies.

Prefilled Syringes Market Size 2024 to 2033

Key Pointers

  • North America dominated the global prefilled syringes market with the largest market share of 33% in 2023.
  • By Type, the disposable segment dominated the market with a 92% share in 2023 and is projected to experience the highest growth rate over the forecast period.
  • By Distribution Channel, the hospitals segment contributed the largest market share of 52% in 2023.
  • By Distribution Channel, the mail order pharmacies segment is anticipated to grow the fastest over the forecast period.
  • By Material, the glass segment generated the maximum market share of 52% in 2023.
  • By Application, the vaccines and immunizations segment held the largest share of 26% in 2023.
  • By Application, the oncology segment is expected to grow at the fastest CAGR from 2024 to 2033.

What are the Growth Factors of Prefilled Syringes Market?

The growth of the prefilled syringes market is significantly influenced by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis has created a heightened demand for convenient and reliable drug delivery systems. Prefilled syringes facilitate easier self-administration, which enhances patient compliance and simplifies the management of these conditions. Secondly, advancements in syringe technology, including improved safety features and drug compatibility, are driving market expansion. Innovations such as integrated needle safety mechanisms and enhanced drug stability ensure more accurate dosing and minimize the risk of contamination or needle-stick injuries. Additionally, the rising adoption of biologics, which often require injectable delivery, further boosts the demand for prefilled syringes. These syringes are particularly suited for biologics due to their ability to maintain drug integrity and deliver precise dosages.

What are the Trends in Prefilled Syringes Market?

  • Increased Use of Biologics and Biosimilars: The rising demand for biologics and biosimilars is a major trend driving the prefilled syringes market. These complex drugs often require precise dosing and are best delivered via prefilled syringes to ensure accurate administration and maintain drug stability.
  • Growth in Self-Administration of Medications: There is a growing preference for self-administration among patients, driven by the convenience and ease offered by prefilled syringes. This trend is particularly prominent in the management of chronic conditions such as diabetes and rheumatoid arthritis.
  • Advancements in Safety Features: Innovations in syringe design are enhancing safety, with new models incorporating safety shields and retractable needles to prevent needle-stick injuries and reduce the risk of infection. These advancements are becoming a standard feature, influencing market growth.
  • Development of User-Friendly Designs: The market is seeing a shift towards syringes with ergonomic and user-friendly designs. Features such as easy-to-use plunger mechanisms and clear dosage markings are being integrated to improve the overall patient experience and usability.

What are the Key Challenges Faced by Prefilled Syringes Market?

  • High Manufacturing Costs: The production of prefilled syringes involves sophisticated technology and materials, resulting in higher costs compared to traditional syringes. This cost factor can limit their adoption, especially in cost-sensitive markets.
  • Regulatory Compliance: Prefilled syringes must meet stringent regulatory standards across different regions. Navigating these complex regulations can be challenging for manufacturers, potentially causing delays and increased costs.
  • Compatibility Issues: Ensuring compatibility between the syringe and the drug it delivers is crucial. Variability in drug formulations and the need for precise container-closure systems can pose challenges in maintaining drug efficacy and safety.
  • Risk of Drug Interactions: The interaction between the drug and the syringe material can affect the stability and effectiveness of the medication. Ensuring that materials used in prefilled syringes do not react with the drugs they contain is a critical challenge.

Which Region Dominates the Prefilled Syringes Market?

The prefilled syringes market in North America held a 33% share in 2023. The region prioritizes preventing needlestick injuries among healthcare professionals, and prefilled syringes with needle guards are increasingly used to address this concern. The CDC recommends prefilled syringes for vaccine administration due to their ability to preserve vaccine potency and save time, contributing to market growth.

What is the Contribution of North America to Prefilled Syringes Market?

Attribute North America
Market Value USD 2.40 Billion
Growth Rate 13.09% CAGR
Projected Value USD 8.22 Billion

Europe Prefilled Syringes Market Trends

Europe dominates the global prefilled syringes market, driven by the preference for prefilled injectable devices to reduce needle-related injuries. Government initiatives and prominent market players in the region are fostering the use of single-use medical goods, which is expected to boost market growth.

Prefilled Syringes Market Share, By Region, 2023 (%) 

Asia Pacific Prefilled Syringes Market Trends

The Asia-Pacific market is set for significant expansion due to the presence of numerous FDA, TGA, and EMA-approved facilities. The region's developing economy and large, growing population, coupled with an increasing incidence of chronic conditions, are expected to drive market growth.

Latin America Prefilled Syringes Market Trends

The Latin American prefilled syringes market is experiencing notable growth, fueled by the rising prevalence of chronic diseases like diabetes and rheumatoid arthritis. The aging population, advancements in technology, and expanding biopharmaceuticals sector are further driving demand.

Type Insights

The disposable segment dominated the market with a 92% share in 2023 and is projected to experience the highest growth rate over the forecast period. The increasing trend towards self-injection has heightened the need for safety, which disposable syringes address effectively. These syringes reduce the risk of cross-contamination by allowing for the immediate disposal of needles post-use. They are essential in both diagnostic and therapeutic applications for chronic diseases, which drives their growing demand. For instance, in June 2021, Hindustan Syringes and Medical Devices Ltd. partnered with Star Syringes of the UK to introduce disposable safety needles under the Disposjekt Needle brand, aimed at enhancing safety against sharps injuries.

The reusable segment also held a notable market share in 2023. Reusable syringes with disposable tips can be utilized multiple times, offering cost savings and potentially reducing infection risks when proper safety protocols are observed. For example, replacing auto-injectors with weekly reusable syringes can cut production needs by up to 200 units annually. According to the U.S. FDA, prefilled syringes with disposable tips, such as those used for dental applications, are commonly employed, with the tips discarded after each use while the dispensers are reused.

Distribution Channel Insights

The hospitals segment led the market with a 52% share in 2023. Hospitals are favored for their accessibility and trusted reputation, making them a primary setting for fluid therapies and injections. The CDC estimates that safety measures like prefilled syringes can reduce sharps-related injuries by 60-88%, highlighting their role in enhancing hospital safety protocols.

The mail order pharmacies segment is anticipated to grow the fastest over the forecast period. These pharmacies offer the convenience of direct medication delivery to patients' homes, which is particularly beneficial for those needing regular injections with prefilled syringes. Mail order pharmacies also provide competitive medication pricing, potentially lowering overall healthcare costs, which is attractive for patients with chronic conditions requiring ongoing treatment.

Material Insights

The glass segment accounted for the largest share of 52% in 2023. Glass provides an effective barrier against moisture, oxygen, and light, essential for maintaining medication stability and preventing degradation. Although some plastics also offer good barrier properties, they may not be as effective as glass for certain drugs. Glass syringes also offer excellent clarity, which allows healthcare providers to easily monitor the medication inside.

The plastic segment held a significant market share in 2023 due to its cost-effectiveness compared to glass. Plastic syringes are more affordable to produce, making them accessible in various healthcare settings, especially in emerging markets. Plastic also allows for greater design flexibility, enabling the creation of innovative features like multi-chamber syringes or integrated needle guards, which enhance functionality and safety. These advantages are expected to drive the demand for plastic prefilled syringes.

Application Insights

The vaccines and immunizations segment held the largest share of 26% in 2023. Prefilled syringes are ideal for vaccines, which often require multiple doses over time. They eliminate the need for drawing medication from vials, reducing errors and contamination risks. Prefilled syringes are also easier for patients to use compared to traditional vials, which improves compliance and supports successful vaccination programs. They can be pre-measured and labeled, facilitating easier self-administration at home.

The oncology segment is projected to grow at the fastest rate over the forecast period. Prefilled syringes offer significant benefits for oncology patients undergoing frequent injections, such as those in chemotherapy. They provide easier transport and self-administration compared to traditional vials and syringes, improving patient comfort and independence. Technological advancements, such as multi-chamber syringes, are enhancing the delivery of combination therapies used in cancer treatments, offering greater flexibility and convenience.

Who are the Top Manufactures in Prefilled Syringes Market?

  • BD
  • Gerresheimer AG
  • SCHOTT Pharma AG
  • Stevanato Group
  • Nipro Corporation
  • Terumo
  • West pharmaceuticals
  • Fresenius
  • Catalent
  • Aptar Pharma

Recent Developments

  • May 2023: Schott Pharma introduced prefillable syringes designed for medications requiring storage in extremely cold conditions. This innovation addresses the need for syringes that can maintain the integrity of temperature-sensitive drugs during storage and transport.
  • May 2023: Fresenius Kabi expanded its Simplist prefilled syringe line by adding a new 100mcg per 2mL dose of Fentanyl Citrate Injection. This expansion enhances the company's offering in pain management solutions with precise dosage options.
  • September 2022: Becton Dickinson and Company (BDX) launched an advanced glass prefillable syringe specifically tailored for vaccines. This new syringe features improved specifications for manufacturability, visual quality, contamination control, and overall product integrity, aiming to enhance vaccine delivery and safety.
  • May 2022: SCHOTT inaugurated a new facility dedicated to manufacturing prefillable syringes using cutting-edge polymer materials. This facility aims to leverage innovative materials to improve syringe performance and meet evolving market needs.

Prefilled Syringes Market Segmentation:

By Type

  • Disposable
  • Reusable

By Material

  • Glass
  • Plastic

By Application

  • Vaccines & Immunizations
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Autoimmune Diseases
  • Oncology
  • Others

By Distribution Channel

  • Hospitals
  • Mail Order Pharmacies
  • Ambulatory Surgery Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global prefilled syringes market size was reached at USD 7.28 billion in 2023 and it is projected to hit around USD 24.91 billion by 2033.

The global prefilled syringes market is growing at a compound annual growth rate (CAGR) of 13.09% from 2024 to 2033.

The North America region has accounted for the largest prefilled syringes market share in 2023.

The leading companies operating in the prefilled syringes market are Gerresheimer AG, Schott Group, BD, Unilife Corporation, Nipro Medical Corporation, Owen Mumford, and Haselmeier AG.

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers